1 Research Methodology
2 Research objectives
3 Research Process
4 Report Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope of Study
4.3.1 Market Segmentation by Source Type
4.3.2 Market Segmentation by Methodology
4.3.3 Market Segmentation by Application
4.3.4 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1.1 Inclusions
5.1.2 Exclusions
5.2 Currency Conversion rate
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview Of Nervous System and Neurophysiology
7.2 Introduction to IONM
7.3 Evolution of IONM
7.4 Standard Steps in IONM
7.4.1 Pre-operative Preparation
7.4.2 Baseline IONM Recording
7.4.3 Perioperative IONM Recording
7.4.4 IONM Documentation
7.4.5 Interpretive Report Preparation
7.5 Key Advantages of IONM
8 Reimbursement Scenario
8.1 Reimbursement Scenario in US
8.1.1 Overview of IONM Reimbursement
8.2 Reimbursement Scenario in Canada
8.2.1 Overview of IONM Reimbursement
9 Market Dynamics
9.1 Market Growth Enablers
9.1.1 Increase in Aging Population and Chronic Diseases
9.1.2 Sizeable Increase in Surgical Procedures
9.1.3 Considerable Increase in Hospitals Recommending IONM for Varied Surgeries
9.1.4 Advent of Technologically Advanced IONM Equipment
9.1.5 Increase in Demand for Out-sourced IONM
9.1.6 YOY Impact of Market Enablers
9.2 Market Growth Restraint
9.2.1 Dearth of Skilled IONM Professionals
9.2.2 Lack of Stringent Regulations
9.2.3 High Cost of IONM Utilized Surgeries
9.2.4 Limitations and Complications Associated with IONM
9.2.5 YOY Impact of Market Restraints
9.3 Market Opportunities & Trends
9.3.1 Increased Demand for Remote Neuromonitoring
9.3.2 Advent of Portable and Multi-modality IONM Devices
9.3.3 Increase in Strategic Consolidation
9.3.4 Integration of MI Surgeries with IONM
9.3.5 YOY Impact of Trends and Opportunities
10 Neuromonitoring Market In North America
10.1 Market Overview
10.2 Market Size & Forecast
11 Porter’s Five Forces Analysis
11.1 Threat of New Entrants
11.2 Bargaining Power of Suppliers
11.3 Bargaining Power of Buyers
11.4 Threat of Substitutes
11.5 Competitive Rivalry
12 IONM Market In North America - By Source Type
12.1 Market Overview
12.2 In-Sourced IONM
12.2.1 Market Size & Forecast
12.3 Outsourced IONM
12.3.1 Market Size & Forecast
13 IONM Market in North America by Modality
13.1 Segment Overview
13.2 Evoked Potential
13.2.1 Market Size & Forecast
13.3 Detailed Description of EP Types
13.3.1 Somatosensory Evoked Potentials (SSEP)
13.3.2 Motor Evoked Potentials (MEP)
13.3.3 Visual Evoked Potential
13.3.4 Brainstem Auditory Evoked Potential (BAEPs)
13.4 Electromyography (EMG)
13.4.1 Market Size & Forecast
13.4.2 Free-running EMG
13.4.3 Stimulated EMG
13.5 Electroencephalogram (EEG) Market
14 IONM Market in North America By Application
14.1 Segment Overview
14.2 Neural Surgeries
14.2.1 Market Size & Forecast
14.3 ORthopedic Surgeries
14.4 ENT Surgeries
14.5 CARDIOVasular Surgeries
15 IONM Market in North America By Country
15.1 Segment Overview
15.2 US
15.2.1 Market Size & Forecast
15.3 Leading Trends, Enablers, and Restraints
15.4 Canada
15.4.1 Market Size & Forecast
15.5 Leading Trends, Enablers, and Restraints
16 Competitive Landscape
16.1 market overview
17 Key Company Profiles
17.1 Cadwell Industries INC.
17.1.1 Strength Assessment
17.1.2 Strategy Assessment
17.1.3 Opportunity Assessment
17.2 SpecialtyCare
17.2.1 Key Highlights
17.2.2 Strength Assessment
17.2.3 Strategy Assessment
17.2.4 Opportunity Assessment
17.3 Natus Medical Incorporated (Natus)
17.3.1 Key Highlights
17.3.2 Strength Assessment
17.3.3 Strategy Assessment
17.3.4 Opportunity Assessment
17.4 NuVasive Inc.
17.4.1 Key Highlights
17.4.2 Strength Assessment
17.4.3 Strategy Assessment
17.4.4 Opportunity Assessment
17.5 Medtronic plc
17.5.1 Key Highlights
17.5.2 Strength Assessment
17.5.3 Strategy Assessment
17.5.4 Opportunity Assessment
17.6 inomed Medizintechnik GmbH
17.6.1 Key Highlights
17.6.2 Strength Assessment
17.6.3 Opportunity Assessment
17.6.4 Strategy Assessment
18 Other Prominent Companies
18.1 Accurate Monitoring LLC
18.1.1 Strength Assessment
18.1.2 Strategy Assessment
18.1.3 Opportunity Assessment
18.2 Computational Diagnostics iNC. (CDI)
18.2.1 Strength Assessment
18.2.2 Strategy Assessment
18.2.3 Opportunity Assessment
18.3 Bromedicon Neuromonitoring LLC
18.3.1 Strength Assessment
18.3.2 Strategy Assessment
18.3.3 Opportunity Assessment
18.4 Clinical Neurodiagnostics LLC
18.4.1 Strength Assessment
18.4.2 Strategy Assessment
18.4.3 Opportunity Assessment
18.5 CNS Neuromonitoring
18.5.1 Strength Assessment
18.5.2 Strategy Assessment
18.5.3 Opportunity Assessment
18.6 Dr. Langer Medical GmBH
18.6.1 Strength Assessment
18.6.2 Strategy Assessment
18.6.3 Opportunity Assessment
18.7 IntraNerve LLC
18.7.1 Strength Assessment
18.7.2 Strategy Assessment
18.7.3 Opportunity Assessment
18.8 MEDSURANT HEALTH LLC
18.8.1 Strength Assessment
18.8.2 Strategy Assessment
18.8.3 Opportunity Assessment
18.9 Neuro Alert
18.9.1 Strength Assessment
18.9.2 Strategy Assessment
18.9.3 Opportunity Assessment
18.10 Neuromonitoring Technologies (NMT) INC
18.10.1 Strength Assessment
18.10.2 Strategy Assessment
18.10.3 Opportunity Assessment
18.11 Nihon Kohden CORP.
18.11.1 Strength Assessment
18.11.2 Strategy Assessment
18.11.3 Opportunity Assessment
19 Report Summary
19.1 Key Takeaways
19.2 Qualitative Summary of IONM Market in North Amemrica
19.3 Quantitative Summary of IONM Market in North America 2016–2022
20 Appendix
20.1 List of Abbreviations